Legal status by country
Is Argireline with Matrixyl and SNAP-8 legal?
Written by Aaron CuhaReviewed Sep 2026
How Argireline with Matrixyl and SNAP-8 is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Permitted in cosmetics | Permitted in cosmetics | Permitted in cosmetics | Permitted in cosmetics |
| Note | Sold as cosmetics. No premarket approval; anti-wrinkle appearance claims are permitted, structural claims are not. | Regulated as cosmetics; efficacy claims must be substantiated under the cosmetics regulation. | None recorded | None recorded |
US FDA status: Cosmetic ingredients, not drugs. Cosmetic products are not subject to premarket approval in the United States, and claims that a product changes the structure or function of skin would make it a drug claim.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.